Sponsored by
by Virgo Consumer HEALTH for Seven Seas
by Munro & Forster Communications for Janssen
by 90TEN Healthcare for Daiichi-Sankyo
by Euro RSCG Life Medicom for Bristol-Myers Squibb UK
by OgilvyHealthPR for Boehringer Ingelheim
by OgilvyHealthPR for Boehringer Ingelheim
Boehringer Ingelheim (BI) tasked OgilvyHealth PR with maximising the impact of the European approval of Pradaxa (dabigatran etexilate) to ensure that customers around the world realised the treatment’s true potential, enabling people living with atrial fibrillation (AF) to benefit from this innovative product.
The launch story: overhauling the current model of care and closing a 60-year gap in therapeutic innovation. A comprehensive media campaign was launched, targeting potential prescribers, involving 16 country affiliates, and a high-profile European launch press event prior to local roll out. The embargoed event attracted 55 EU journalists, with coverage reaching in excess of nine million people on the first day alone.
In a short space of time, this team achieved a lot against high expectations. The campaign achieved enormous output in terms of coverage through strong creative ideas.
Associate director: Global projects, which bring numerous countries together, can be notoriously difficult, given individual country aims and launch timelines. This approach succeeded in mobilising our colleagues to deliver the widespread coverage befitting the positive shift in care, which dabigatran etexilate provides to healthcare professional and patients alike.
Dr Richard White, MP PhD, Oxford PharmaGenesis - Communiqué Judge
Entry deadline | 11 March 2022 |
Extended entry deadline | 18 March 2022 (additional fee applies) |
Judging days | May 2022 |
Awards Ceremony | 7th July 2022 |
For sponsorship opportunities:
Sales Team
sales@pmlive.com
Tel: +44 (0)1372 414200
General event enquiries:
Debbie Tuesley
dtuesley@pmlive.com
Tel: +44 (0)1372 414243
Entry and dinner booking enquiries:
Saoirse Meenaghan
Email: smeenaghan@pmlive.com
Tel: 01372 414253